Hummingbird Bioscience Licenses Monoclonal Antibodies To Immunome For Exclusive Worldwide Use, Receives Upfront Payment And Potential Milestone Payments, Royalties

BenzingaJan 7 08:20 ET

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BusinesswireDec 2, 2024 18:26 ET

Express News | Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

ReutersDec 2, 2024 18:26 ET

Immunome to Present at the Piper Sandler 36th Annual Healthcare Conference

BusinesswireNov 27, 2024 08:00 ET

Immunome President Acquires 24% More Stock

Simply Wall StNov 27, 2024 05:19 ET

Immunome Insider Bought Shares Worth $962,181, According to a Recent SEC Filing

MT NewswiresNov 25, 2024 09:05 ET